NGT3 is a unique venture capital fund and partnership, with European, American and Israeli partners, who share the vision of investment in early-stage technology-based start-up companies with social agenda. NGT3 brings new opportunities while remaining rooted in Nazareth, the largest Arab city in Israel’s Galilee. We start and fund early-stage companies, primarily in innovative medical devices and life sciences, and encourage Arab and Jewish entrepreneurship. NGT3 companies operate within the framework of an Israeli government-licensed technological incubator.
NGT3 is an early-stage VC, focused on medical technologies. We’ve been working with MSCOMMS for several years now, getting support for us and for our portfolio companies.
mscomms are exceptionally creative in finding the story, the angle, and the right media channel to publish. Both Iris and her staff are professional, service-oriented, very pleasant, and doers – pushing every opportunity and creating opportunities, to get maximal exposure